Page 19 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vestmark Advisory Solutions Inc. lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 56.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 16,889 shares of the medical research company’s stock after selling 21,481 shares during the […]

Flputnam Investment Management Co. decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 0.2% during the third quarter, HoldingsChannel reports. The fund owned 57,475 shares of the medical research company’s stock after selling 114 shares during the quarter. Flputnam Investment Management Co.’s holdings in Charles River Laboratories International […]

Girard Partners LTD. raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.2% during the 3rd quarter, Holdings Channel reports. The fund owned 21,756 shares of the medical research company’s stock after purchasing an additional 1,076 shares during the period. Girard Partners LTD.’s holdings in Charles River Laboratories […]

Advisor OS LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 66.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,538 shares of the medical research company’s stock after purchasing an additional 5,794 […]

Congress Wealth Management LLC DE increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 53,514 shares of the medical research company’s stock after buying an […]